Thursday, January 28, 2010 10:58:40 AM
Skinvisible Licensee Receives Reorder from Walgreens
New First Aid Antiseptic Product Made With Invisicare Selling Nationwide
LAS VEGAS, Jan. 28, 2010 (GLOBE NEWSWIRE) -- Skinvisible, Inc.’s (OTCBB:SKVI - News) licensee, JD Nelson and Associates LLC, announced today that reorders have been received as a result of the successful launch last week of their new product Safe4Hours® First Aid Antiseptic Skin Protectant in over 7,000 Walgreens stores (NYSE:WAG - News). Re-orders have been received from eleven of twelve distribution centers. JD Nelson licensed Skinvisible’s newly formulated first aid antiseptic lotion, a product which is formulated with the benefits of the Company’s patented Invisicare® delivery system. Safe4Hours® First Aid Antiseptic Skin Protectant with Invisicare binds to the skin, resisting both wash off and perspiration while continuing to kill bacteria for up to four hours and longer (www.safe4hours.com).
“We are very pleased with JD Nelson’s successful product launch with Walgreens, the nation’s largest pharmacy chain,” said Mr. Terry Howlett, President and CEO of Skinvisible Pharmaceuticals, Inc. “We anticipate further growth as their marketing campaign which includes print, radio and TV, ramps up over the next several weeks. We have recently shipped additional Invisicare polymer to fulfill their Walgreens re-order and we foresee continuous orders as they expand their distribution with additional mass merchandisers and pharmacy chains. Additionally, they are experiencing brisk sales of Safe4Hours skin protectant in Canada where it is available in Rexall, PharmaSave, Lawtons, Guardian and other pharmacy chains.”
Safe4Hours® First Aid Antiseptic Skin Protectant helps to prevent infections by reducing a broad spectrum of bacteria, including MSRA on minor cuts, scrapes, and burns as well as protecting and relieving chaffed, chapped, cracked and dry skin. Safe4Hours promotes the healing process by allowing the skin to retain its natural moisture.
According to the Center for Disease Control (CDC), MRSA (methicillin-resistant Staphylococcus aureus), a staph infection that causes severe infections, can be found almost anywhere in the community. Of the 12 million annual doctor visits for skin infections, MRSA is the cause in more than half. MRSA can be spread through contact with infected skin, surfaces or personal items such as towels. The CDC recommends parents be vigilant about their children’s hygiene. Initially just a hospital acquired infection, MRSA can now is commonly found in schools, dormitories, athletic facilities, military barracks, households, pris
Recent SKVI News
- Form 8-K - Current report • Edgar (US Regulatory) • 10/25/2023 05:05:54 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2023 07:11:08 PM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM